Life

U.S. ‘Pauses’ Johnson & Johnson Vaccine After Clotting Reports

The U.S. is recommending a “pause” in administrating the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination.

All six were women between the ages of 18 and 48; one died and a second is hospitalized in critical condition.

More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

If you’ve gotten the vaccine, which one did you get? Did you have any side effects?


Subscribe to X96's News!

Get the latest music news, contests and flyaways, and more straight to your inbox with our weekly emails.

* indicates required
Comments
To Top